                         SEQUENCE LISTING

<110>  F. Hoffmann-La Roche Ltd
 
<120>  Methods for assessing transendothelial barrier integrity

<130>  P34956

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  CAS9 targeting site

<400>  1
gcgaggcgtt ggataagcct                                                   20


<210>  2
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  TK forward primer

<400>  2
gtacccgagc cgatgactta c                                                 21


<210>  3
<211>  16
<212>  DNA
<213>  Artificial sequence

<220>
<223>  TK reverse primer

<400>  3
cccggccgat atctca                                                       16


<210>  4
<211>  29
<212>  DNA
<213>  Artificial sequence

<220>
<223>  TK probe

<400>  4
cttccgagac aatcgcgaac atctacacc                                         29


<210>  5
<211>  15
<212>  DNA
<213>  Artificial sequence

<220>
<223>  RPP30 forward primer

<400>  5
gatttggacc tgcga                                                        15


<210>  6
<211>  15
<212>  DNA
<213>  Artificial sequence

<220>
<223>  RPP30 reverse primer

<400>  6
gcggctgtct ccaca                                                        15


<210>  7
<211>  16
<212>  DNA
<213>  Artificial sequence

<220>
<223>  RPP30 probe

<400>  7
ctgacctgaa ggctct                                                       16


<210>  8
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  R1 primer

<400>  8
ggctggacag agaacaggac                                                   20


<210>  9
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  F2 primer

<400>  9
gcccccgaac cttcaaaga                                                    19


<210>  10
<211>  18
<212>  DNA
<213>  Artificial sequence

<220>
<223>  R2 primer

<400>  10
ctgcacgccg taggtcag                                                     18


<210>  11
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  F3 primer

<400>  11
ggagatgggg gaggctaact                                                   20


<210>  12
<211>  12
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Figure 1f - sequence 1

<400>  12
tacgtcggaa gc                                                           12


<210>  13
<211>  12
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Figure 1f - sequence 2

<400>  13
ggacctatgg tg                                                           12


<210>  14
<211>  15
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Figure 1f - sequence 3

<400>  14
tacaagtgag ggcgc                                                        15


<210>  15
<211>  16
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Figure 1f - sequence 4

<400>  15
cgttggttaa gcctgg                                                       16


